388 related articles for article (PubMed ID: 27227542)
1. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
Hsu CC; Watkins TW; Kwan GN; Haacke EM
J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
[TBL] [Abstract][Full Text] [Related]
3. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
5. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
[TBL] [Abstract][Full Text] [Related]
6. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
7. Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma.
Fahrendorf D; Hesselmann V; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Heindel W; Bink A
J Neuroimaging; 2015; 25(6):1015-22. PubMed ID: 25703027
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD
Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779
[TBL] [Abstract][Full Text] [Related]
9. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging.
Radbruch A; Wiestler B; Kramp L; Lutz K; Bäumer P; Weiler M; Roethke M; Sahm F; Schlemmer HP; Wick W; Heiland S; Bendszus M
Eur J Radiol; 2013 Mar; 82(3):552-6. PubMed ID: 23238364
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T.
Kang H; Jang S
Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747
[TBL] [Abstract][Full Text] [Related]
13. Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme.
Fahrendorf D; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Grauer O; Heindel W; Hesselmann V; Bink A
Eur Radiol; 2013 Oct; 23(10):2868-79. PubMed ID: 23903995
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
Ding Y; Xing Z; Liu B; Lin X; Cao D
Brain Behav; 2014; 4(6):841-9. PubMed ID: 25365807
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
[TBL] [Abstract][Full Text] [Related]
18. Role of susceptibility-weighted imaging and intratumoral susceptibility signals in grading and differentiating pediatric brain tumors at 1.5 T: a preliminary study.
Gaudino S; Marziali G; Pezzullo G; Guadalupi P; Giordano C; Infante A; Benenati M; Ramaglia A; Massimi L; Gessi M; Frassanito P; Caldarelli M; Colosimo C
Neuroradiology; 2020 Jun; 62(6):705-713. PubMed ID: 32140783
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
[TBL] [Abstract][Full Text] [Related]
20. High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.
Tanji M; Mineharu Y; Sakata A; Okuchi S; Fushimi Y; Oishi M; Terada Y; Sano N; Yamao Y; Arakawa Y; Yoshida K; Miyamoto S
J Neurosurg; 2023 Jan; 138(1):120-127. PubMed ID: 35561695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
